4.7 Article

The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid Cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Patient Preparation and Radiation Protection Guidance for Adult Patients Undergoing Radioiodine Treatment for Thyroid Cancer in the UK

J. Wadsley et al.

Summary: Radioactive iodine is an effective treatment for thyroid cancer, but its use can be complex for patients due to dietary restrictions and radiation protection precautions. Variations in practice have been observed in the UK, leading to unnecessary burdens for some patients. To address this, a multidisciplinary group has developed guidance on patient preparation and radiation protection, as well as a patient information leaflet, in order to personalize the advice given to individual patients and improve their experience of receiving radioactive iodine treatment.

CLINICAL ONCOLOGY (2023)

Article Oncology

Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA)

Alan L. Ho et al.

Summary: This study investigated whether adding Selumetinib to adjuvant RAI improves complete remission rates in patients with DTC at high risk of primary treatment failure. The results showed that Selumetinib did not significantly increase the CR rate 18 months after RAI, and treatment-related adverse events were minimal.

JOURNAL OF CLINICAL ONCOLOGY (2022)

News Item Biochemistry & Molecular Biology

Theranostics could be big business in precision oncology

Carrie Arnold

Summary: Theranostics aims to address both diagnosis and treatment of cancer, with only a few drugs available on the market currently, but promising results from clinical trials.

NATURE MEDICINE (2022)

Article Endocrinology & Metabolism

The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020

Margherita Pizzato et al.

Summary: The incidence rates of thyroid cancer in 2020 were higher in high human development index countries compared to low and medium human development index countries. However, mortality rates were relatively similar across different settings. This suggests an overdiagnosis effect in many countries and confirms the relevance of thyroid cancer overdiagnosis as a global public health problem.

LANCET DIABETES & ENDOCRINOLOGY (2022)

Article Engineering, Biomedical

Standardised quantitative radioiodine SPECT/CT Imaging for multicentre dosimetry trials in molecular radiotherapy

Rebecca A. Gregory et al.

PHYSICS IN MEDICINE AND BIOLOGY (2019)

Review Oncology

Radioiodine refractory differentiated thyroid cancer

Yuchen Jin et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations

Jonathan I. Gear et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

124I PET Assessment of Response of Bone Metastases to Initial Radioiodine Treatment of Differentiated Thyroid Cancer

Walter Jentzen et al.

JOURNAL OF NUCLEAR MEDICINE (2016)

Editorial Material Endocrinology & Metabolism

Definition and management of radioactive iodine-refractory differentiated thyroid cancer

Martin Schlumberger et al.

LANCET DIABETES & ENDOCRINOLOGY (2014)

Article Medicine, General & Internal

Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer

Alan L. Ho et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Medicine, Research & Experimental

Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation

Debyani Chakravarty et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Review Radiology, Nuclear Medicine & Medical Imaging

Thyroid Stunning: Fact or Fiction?

I. Ross McDougall et al.

SEMINARS IN NUCLEAR MEDICINE (2011)

Article Oncology

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. A. Eisenhauer et al.

EUROPEAN JOURNAL OF CANCER (2009)

Article Radiology, Nuclear Medicine & Medical Imaging

MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry-Standardization of Nomenclature

Wesley E. Bolch et al.

JOURNAL OF NUCLEAR MEDICINE (2009)

Article Radiology, Nuclear Medicine & Medical Imaging

EANM Dosimetry Committee series on standard operational rocedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy

Michael Lassmann et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)

Review Radiology, Nuclear Medicine & Medical Imaging

Clinical radionuclide therapy dosimetry: the quest for the Holy Gray

B. Brans et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)

Article Radiology, Nuclear Medicine & Medical Imaging

Verification of the agreement of two dosimetric methods with radioiodine therapy in hyperthyroid patients

Cristina Canzi et al.

MEDICAL PHYSICS (2006)

Article Environmental Sciences

Physical models and dose factors for use in internal dose assessment

MG Stabin et al.

HEALTH PHYSICS (2003)

Article Radiology, Nuclear Medicine & Medical Imaging

Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy

B de Keizer et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)

Article Engineering, Biomedical

Estimation and implications of random errors in whole-body dosimetry for targeted radionuclide therapy

GD Flux et al.

PHYSICS IN MEDICINE AND BIOLOGY (2002)